speb/financial-data huggingface dataset:
AMRN cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -278000.00
AMRN cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 345000.00
AMRN cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -10496000.00
AMRN cash_flow (annual, 2023-12-31) — Change In Payable: -164000.00
AMRN cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -164000.00
AMRN cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 7874000.00
AMRN cash_flow (annual, 2023-12-31) — Change In Receivables: -2325000.00
AMRN cash_flow (annual, 2023-12-31) — Change In Working Capital: 51077000.00
AMRN cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -2573000.00
AMRN cash_flow (annual, 2023-12-31) — Changes In Cash: -18412000.00
AMRN balance_sheet (annual, 2023-12-31) — Common Stock: 302756000.00
AMRN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 552097000.00
AMRN income_statement (annual, 2023-12-31) — Cost Of Revenue: 141370000.00
AMRN balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 181152000.00
AMRN balance_sheet (annual, 2023-12-31) — Current Assets: 724981000.00
AMRN balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 2341000.00
AMRN balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 2341000.00
AMRN balance_sheet (annual, 2023-12-31) — Current Liabilities: 259277000.00
AMRN cash_flow (annual, 2023-12-31) — Depreciation: 160000.00
AMRN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2965000.00
AMRN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2965000.00
AMRN income_statement (annual, 2023-12-31) — Diluted Average Shares: 20382750.00
AMRN income_statement (annual, 2023-12-31) — Diluted EPS: -3.00
AMRN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -59112000.00
AMRN income_statement (annual, 2023-12-31) — EBIT: -53662000.00
AMRN income_statement (annual, 2023-12-31) — EBITDA: -50697000.00
AMRN cash_flow (annual, 2023-12-31) — End Cash Position: 199777000.00
AMRN cash_flow (annual, 2023-12-31) — Financing Cash Flow: 230000.00
AMRN cash_flow (annual, 2023-12-31) — Free Cash Flow: 6347000.00
AMRN income_statement (annual, 2023-12-31) — General And Administrative Expense: 88612000.00
AMRN balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 19304000.00
AMRN balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 160686000.00
AMRN balance_sheet (annual, 2023-12-31) — Gross PPE: 9803000.00
AMRN income_statement (annual, 2023-12-31) — Gross Profit: 165541000.00
AMRN cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 2367000.00
AMRN income_statement (annual, 2023-12-31) — Interest Expense: 8000.00
AMRN income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 8000.00
AMRN income_statement (annual, 2023-12-31) — Interest Income: 11863000.00
AMRN income_statement (annual, 2023-12-31) — Interest Income Non Operating: 11863000.00
AMRN balance_sheet (annual, 2023-12-31) — Inventory: 258616000.00
AMRN balance_sheet (annual, 2023-12-31) — Invested Capital: 552097000.00
AMRN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -25522000.00
AMRN balance_sheet (annual, 2023-12-31) — Investments And Advances: 0.00
AMRN balance_sheet (annual, 2023-12-31) — Leases: 217000.00
AMRN balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 8737000.00
AMRN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 8737000.00
AMRN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1276000.00
AMRN income_statement (annual, 2023-12-31) — Net Income: -59112000.00
AMRN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -59112000.00
AMRN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -59112000.00
AMRN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -59112000.00
AMRN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -59112000.00
AMRN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -59112000.00
AMRN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -59112000.00
AMRN cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -509000.00
AMRN income_statement (annual, 2023-12-31) — Net Interest Income: 11855000.00
AMRN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -24989000.00
AMRN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 11855000.00
AMRN cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1982000.00
AMRN balance_sheet (annual, 2023-12-31) — Net PPE: 8424000.00
AMRN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -24000.00
AMRN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 532793000.00
AMRN balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 2509000.00
AMRN balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 2509000.00
AMRN income_statement (annual, 2023-12-31) — Normalized EBITDA: -39725000.00
AMRN income_statement (annual, 2023-12-31) — Normalized Income: -50444120.00
AMRN cash_flow (annual, 2023-12-31) — Operating Cash Flow: 6880000.00
AMRN income_statement (annual, 2023-12-31) — Operating Income: -56616000.00
AMRN income_statement (annual, 2023-12-31) — Operating Revenue: 306911000.00
AMRN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 408824093.00
AMRN balance_sheet (annual, 2023-12-31) — Other Current Assets: 11618000.00
AMRN balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 23022000.00
AMRN income_statement (annual, 2023-12-31) — Other Gand A: 76119000.00
AMRN income_statement (annual, 2023-12-31) — Other Income Expense: -8909000.00
AMRN balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 19304000.00
AMRN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 78975000.00
AMRN balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 9064000.00
AMRN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2063000.00
AMRN balance_sheet (annual, 2023-12-31) — Other Properties: 8310000.00
AMRN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 121407000.00
AMRN balance_sheet (annual, 2023-12-31) — Payables: 52762000.00
AMRN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 233914000.00
AMRN income_statement (annual, 2023-12-31) — Pretax Income: -53670000.00
AMRN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 2212000.00
AMRN balance_sheet (annual, 2023-12-31) — Properties: 0.00
AMRN cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -509000.00
AMRN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -215097000.00
AMRN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -24000.00
AMRN balance_sheet (annual, 2023-12-31) — Receivables: 133563000.00
AMRN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 141370000.00
AMRN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2965000.00
AMRN income_statement (annual, 2023-12-31) — Research And Development: 22219000.00
AMRN balance_sheet (annual, 2023-12-31) — Restricted Cash: 525000.00
AMRN income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 10972000.00
AMRN balance_sheet (annual, 2023-12-31) — Retained Earnings: -1586363000.00
AMRN income_statement (annual, 2023-12-31) — Salaries And Wages: 12493000.00
AMRN cash_flow (annual, 2023-12-31) — Sale Of Investment: 190108000.00
AMRN income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 111326000.00
AMRN income_statement (annual, 2023-12-31) — Selling General And Administration: 199938000.00
AMRN balance_sheet (annual, 2023-12-31) — Share Issued: 418141295.00
AMRN income_statement (annual, 2023-12-31) — Special Income Charges: -10972000.00
AMRN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 15646000.00
AMRN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 552097000.00
AMRN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 532793000.00
AMRN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -2304120.00
AMRN income_statement (annual, 2023-12-31) — Tax Provision: 5442000.00
AMRN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
AMRN balance_sheet (annual, 2023-12-31) — Total Assets: 831684000.00
AMRN balance_sheet (annual, 2023-12-31) — Total Capitalization: 552097000.00
AMRN balance_sheet (annual, 2023-12-31) — Total Debt: 8737000.00
AMRN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 552097000.00
AMRN income_statement (annual, 2023-12-31) — Total Expenses: 363527000.00
AMRN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 279587000.00
AMRN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 106703000.00
AMRN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 20310000.00
AMRN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -67588000.00
AMRN income_statement (annual, 2023-12-31) — Total Unusual Items: -10972000.00
AMRN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -10972000.00
AMRN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 9317202.00
AMRN balance_sheet (annual, 2023-12-31) — Treasury Stock: 63752000.00
AMRN balance_sheet (annual, 2023-12-31) — Working Capital: 465704000.00
AMRN cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: 0.00
AMRN cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
AMRN balance_sheet (quarterly, 2024-09-30) — Current Deferred Liabilities: 0.00
AMRN balance_sheet (quarterly, 2024-09-30) — Current Deferred Revenue: 0.00
AMRN cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
AMRN cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
AMRN cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 0.00
AMRN balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Liabilities: 0.00
AMRN balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Revenue: 0.00
AMRN cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: 0.00
AMRN income_statement (annual, 2024-12-31) — +Operating Expense: 173179000.00
AMRN income_statement (annual, 2024-12-31) — +Total Revenue: 228614000.00
AMRN balance_sheet (annual, 2024-12-31) — Accounts Payable: 40366000.00
AMRN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 122279000.00
AMRN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1470000.00
AMRN balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1470000.00
AMRN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1914750000.00
AMRN balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -10793000.00
AMRN cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 2915000.00
AMRN cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 2915000.00
AMRN cash_flow (annual, 2024-12-31) — Amortization Of Securities: -5729000.00
AMRN income_statement (annual, 2024-12-31) — Basic Average Shares: 20546850.00
AMRN income_statement (annual, 2024-12-31) — Basic EPS: -4.00
AMRN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 199777000.00
AMRN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 7723000.00
AMRN balance_sheet (annual, 2024-12-31) — Capital Stock: 305298000.00
AMRN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 121038000.00
AMRN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 294220000.00
AMRN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1443000.00
AMRN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -45976000.00
AMRN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -31020000.00
AMRN cash_flow (annual, 2024-12-31) — Change In Account Payable: -76987000.00
AMRN cash_flow (annual, 2024-12-31) — Change In Inventory: 105443000.00
AMRN cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 147000.00
AMRN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 2141000.00
AMRN cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -4850000.00
AMRN cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 0.00
AMRN cash_flow (annual, 2024-12-31) — Change In Payable: -76987000.00
AMRN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -76987000.00
AMRN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -934000.00
AMRN cash_flow (annual, 2024-12-31) — Change In Receivables: 11214000.00
AMRN cash_flow (annual, 2024-12-31) — Change In Working Capital: 36174000.00
AMRN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 11284000.00
AMRN cash_flow (annual, 2024-12-31) — Changes In Cash: -78439000.00
AMRN balance_sheet (annual, 2024-12-31) — Common Stock: 305298000.00
AMRN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 486176000.00
AMRN income_statement (annual, 2024-12-31) — Cost Of Revenue: 147232000.00
AMRN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 122038000.00
AMRN balance_sheet (annual, 2024-12-31) — Current Assets: 595399000.00
AMRN balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
AMRN balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 0.00
AMRN balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 0.00
AMRN balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 0.00
AMRN balance_sheet (annual, 2024-12-31) — Current Liabilities: 179949000.00
AMRN cash_flow (annual, 2024-12-31) — Depreciation: 98000.00
AMRN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 3013000.00
AMRN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 3013000.00
AMRN income_statement (annual, 2024-12-31) — Diluted Average Shares: 20546850.00
AMRN income_statement (annual, 2024-12-31) — Diluted EPS: -4.00
AMRN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -82183000.00
AMRN income_statement (annual, 2024-12-31) — EBIT: -77193000.00
AMRN income_statement (annual, 2024-12-31) — EBITDA: -74180000.00
AMRN cash_flow (annual, 2024-12-31) — End Cash Position: 121338000.00
AMRN cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1443000.00
AMRN cash_flow (annual, 2024-12-31) — Free Cash Flow: -31020000.00
AMRN income_statement (annual, 2024-12-31) — General And Administrative Expense: 72723000.00
AMRN balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 16389000.00
AMRN balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 133072000.00
AMRN balance_sheet (annual, 2024-12-31) — Gross PPE: 9078000.00
AMRN income_statement (annual, 2024-12-31) — Gross Profit: 81382000.00
AMRN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 3982000.00
AMRN income_statement (annual, 2024-12-31) — Interest Expense: 7000.00
AMRN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 7000.00
AMRN income_statement (annual, 2024-12-31) — Interest Income: 13403000.00
AMRN income_statement (annual, 2024-12-31) — Interest Income Non Operating: 13403000.00
AMRN balance_sheet (annual, 2024-12-31) — Inventory: 166048000.00
AMRN balance_sheet (annual, 2024-12-31) — Invested Capital: 486176000.00
AMRN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -45976000.00
AMRN balance_sheet (annual, 2024-12-31) — Leases: 217000.00
AMRN balance_sheet (quarterly, 2024-12-31) — Leases: 217000.00
AMRN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 7723000.00
AMRN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 7723000.00
AMRN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1269000.00
AMRN balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1269000.00
AMRN income_statement (annual, 2024-12-31) — Net Income: -82183000.00
AMRN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -82183000.00
AMRN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -82183000.00
AMRN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -82183000.00
AMRN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -82183000.00
AMRN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -82183000.00
AMRN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -82183000.00
AMRN cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
AMRN income_statement (annual, 2024-12-31) — Net Interest Income: 13396000.00
AMRN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -45976000.00
AMRN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 13396000.00
AMRN cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1574000.00
AMRN balance_sheet (annual, 2024-12-31) — Net PPE: 7608000.00
AMRN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
AMRN cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
AMRN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 469787000.00
AMRN balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 0.00
AMRN balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 0.00
AMRN balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 0.00
AMRN balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 0.00
AMRN income_statement (annual, 2024-12-31) — Normalized EBITDA: -74180000.00
AMRN income_statement (annual, 2024-12-31) — Normalized Income: -82183000.00
AMRN cash_flow (annual, 2024-12-31) — Operating Cash Flow: -31020000.00
AMRN income_statement (annual, 2024-12-31) — Operating Income: -91797000.00
AMRN income_statement (annual, 2024-12-31) — Operating Revenue: 228614000.00
AMRN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 411584851.00
AMRN balance_sheet (annual, 2024-12-31) — Other Current Assets: 12552000.00
AMRN balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 17545000.00
AMRN balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 17545000.00
AMRN income_statement (annual, 2024-12-31) — Other Gand A: 58557000.00
AMRN income_statement (annual, 2024-12-31) — Other Income Expense: 1201000.00
AMRN balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 16389000.00
AMRN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 65953000.00
AMRN balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 11501000.00
AMRN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 1201000.00
AMRN balance_sheet (annual, 2024-12-31) — Other Properties: 7592000.00
AMRN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 173182000.00
AMRN balance_sheet (annual, 2024-12-31) — Payables: 40366000.00
AMRN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 162404000.00
AMRN income_statement (annual, 2024-12-31) — Pretax Income: -77200000.00
AMRN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 131000.00
AMRN cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 121000.00
AMRN balance_sheet (annual, 2024-12-31) — Properties: 0.00
AMRN balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
AMRN cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
AMRN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -278776000.00
AMRN cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
AMRN cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
AMRN balance_sheet (annual, 2024-12-31) — Receivables: 122279000.00
AMRN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 147232000.00
AMRN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 3013000.00
AMRN income_statement (annual, 2024-12-31) — Research And Development: 20869000.00
AMRN balance_sheet (annual, 2024-12-31) — Restricted Cash: 300000.00
AMRN income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
AMRN balance_sheet (annual, 2024-12-31) — Retained Earnings: -1668546000.00
AMRN income_statement (annual, 2024-12-31) — Salaries And Wages: 14166000.00
AMRN cash_flow (annual, 2024-12-31) — Sale Of Investment: 232800000.00
AMRN income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 79587000.00
AMRN income_statement (annual, 2024-12-31) — Selling General And Administration: 152310000.00
AMRN balance_sheet (annual, 2024-12-31) — Share Issued: 422256900.00
AMRN income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
AMRN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 17705000.00
AMRN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 486176000.00
AMRN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 469787000.00
AMRN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
AMRN income_statement (annual, 2024-12-31) — Tax Provision: 4983000.00
AMRN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
AMRN balance_sheet (annual, 2024-12-31) — Total Assets: 685349000.00
AMRN balance_sheet (annual, 2024-12-31) — Total Capitalization: 486176000.00
AMRN balance_sheet (annual, 2024-12-31) — Total Debt: 7723000.00
AMRN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 486176000.00
AMRN income_statement (annual, 2024-12-31) — Total Expenses: 320411000.00
AMRN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 199173000.00
AMRN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 89950000.00
AMRN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 19224000.00
AMRN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -91797000.00
AMRN income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
AMRN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
AMRN balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 10672049.00
AMRN balance_sheet (annual, 2024-12-31) — Treasury Stock: 65326000.00
AMRN balance_sheet (annual, 2024-12-31) — Working Capital: 415450000.00
AMRN income_statement (quarterly, 2025-03-31) — +Operating Expense: 41885000.00
AMRN income_statement (quarterly, 2025-03-31) — +Total Revenue: 42017000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 45661000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 106734000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1916223000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -11943000.00
AMRN cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 729000.00
AMRN cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 729000.00
AMRN cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -1216000.00
AMRN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 20671100.00
AMRN income_statement (quarterly, 2025-03-31) — Basic EPS: -0.80
AMRN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 121338000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 7940000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 308152000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 119524000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 281787000.00
AMRN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1119000.00
AMRN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 12064000.00
AMRN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -12459000.00
AMRN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -17541000.00
AMRN cash_flow (quarterly, 2025-03-31) — Change In Inventory: 13894000.00
AMRN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 39000.00
AMRN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -413000.00
AMRN cash_flow (quarterly, 2025-03-31) — Change In Payable: -17541000.00
AMRN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -17541000.00
AMRN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -12577000.00
AMRN cash_flow (quarterly, 2025-03-31) — Change In Receivables: 15995000.00
AMRN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -603000.00
AMRN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 15545000.00
AMRN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1514000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Common Stock: 308152000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 473687000.00
AMRN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 16887000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 116747000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Current Assets: 573061000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 162408000.00
AMRN cash_flow (quarterly, 2025-03-31) — Depreciation: 1000.00
AMRN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 730000.00
AMRN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 730000.00
AMRN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 20671100.00
AMRN income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.80
AMRN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -15697000.00
AMRN income_statement (quarterly, 2025-03-31) — EBIT: -16755000.00
AMRN income_statement (quarterly, 2025-03-31) — EBITDA: -16025000.00
AMRN cash_flow (quarterly, 2025-03-31) — End Cash Position: 119824000.00
AMRN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1119000.00
AMRN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -12459000.00
AMRN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 19652000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 15660000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 118677000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 8378000.00
AMRN income_statement (quarterly, 2025-03-31) — Gross Profit: 25130000.00
AMRN cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 22000.00
AMRN income_statement (quarterly, 2025-03-31) — Interest Income: 2872000.00
AMRN income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2872000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Inventory: 159490000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 473687000.00
AMRN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 12064000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 7940000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 7940000.00
AMRN income_statement (quarterly, 2025-03-31) — Net Income: -15697000.00
AMRN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -15697000.00
AMRN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -15697000.00
AMRN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -15697000.00
AMRN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -15697000.00
AMRN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -15697000.00
AMRN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -15697000.00
AMRN income_statement (quarterly, 2025-03-31) — Net Interest Income: 2872000.00
AMRN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 12064000.00
AMRN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 2872000.00
AMRN cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1119000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Net PPE: 8378000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 458027000.00
AMRN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -16025000.00
AMRN income_statement (quarterly, 2025-03-31) — Normalized Income: -15697000.00
AMRN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -12459000.00
AMRN income_statement (quarterly, 2025-03-31) — Operating Income: -16755000.00
AMRN income_statement (quarterly, 2025-03-31) — Operating Revenue: 42017000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 414365189.00
AMRN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 24750000.00
AMRN income_statement (quarterly, 2025-03-31) — Other Gand A: 16124000.00
AMRN income_statement (quarterly, 2025-03-31) — Other Income Expense: 253000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 15660000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 58578000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 11642000.00
AMRN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 253000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Other Properties: 8378000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 162263000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Payables: 45661000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 162408000.00
AMRN income_statement (quarterly, 2025-03-31) — Pretax Income: -13630000.00
AMRN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
AMRN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -42936000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Receivables: 106734000.00
AMRN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 16887000.00
AMRN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 730000.00
AMRN income_statement (quarterly, 2025-03-31) — Research And Development: 5312000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 300000.00
AMRN income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
AMRN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1684243000.00
AMRN income_statement (quarterly, 2025-03-31) — Salaries And Wages: 3528000.00
AMRN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 55000000.00
AMRN income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 16921000.00
AMRN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 36573000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Share Issued: 426842579.00
AMRN income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
AMRN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 4327000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 473687000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 458027000.00
AMRN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AMRN income_statement (quarterly, 2025-03-31) — Tax Provision: 2067000.00
AMRN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
AMRN balance_sheet (quarterly, 2025-03-31) — Total Assets: 655677000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 473687000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Total Debt: 7940000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 473687000.00
AMRN income_statement (quarterly, 2025-03-31) — Total Expenses: 58772000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 181990000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 82616000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 19582000.00
AMRN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -16755000.00
AMRN income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
AMRN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
AMRN balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 12477390.00
AMRN balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 66445000.00
AMRN balance_sheet (quarterly, 2025-03-31) — Working Capital: 410653000.00
AMRN income_statement (quarterly, 2025-06-30) — +Operating Expense: 43588000.00
AMRN income_statement (quarterly, 2025-06-30) — +Total Revenue: 72741000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 44711000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 119130000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1920993000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -14974000.00
AMRN cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 728000.00
AMRN cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 728000.00
AMRN cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -973000.00
AMRN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 20723850.00
AMRN income_statement (quarterly, 2025-06-30) — Basic EPS: -0.60
AMRN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 119824000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 7640000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 7338000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 309421000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 147877000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 298704000.00
AMRN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -663000.00
AMRN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 12410000.00
AMRN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 16606000.00
AMRN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 23538000.00
AMRN cash_flow (quarterly, 2025-06-30) — Change In Inventory: 6064000.00
AMRN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 39000.00
AMRN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 397000.00
AMRN cash_flow (quarterly, 2025-06-30) — Change In Payable: 23538000.00
AMRN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 23538000.00
AMRN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 7338000.00
AMRN cash_flow (quarterly, 2025-06-30) — Change In Receivables: -12426000.00
AMRN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 24950000.00
AMRN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -12396000.00
AMRN cash_flow (quarterly, 2025-06-30) — Changes In Cash: 28353000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Common Stock: 309421000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 464924000.00
AMRN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 22379000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 141235000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Current Assets: 606819000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 185946000.00
AMRN cash_flow (quarterly, 2025-06-30) — Depreciation: 1000.00
AMRN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 729000.00
AMRN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 729000.00
AMRN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 20723850.00
AMRN income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.60
AMRN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -14139000.00
AMRN income_statement (quarterly, 2025-06-30) — EBIT: 6774000.00
AMRN income_statement (quarterly, 2025-06-30) — EBITDA: 7503000.00
AMRN cash_flow (quarterly, 2025-06-30) — End Cash Position: 148177000.00
AMRN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -663000.00
AMRN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 16606000.00
AMRN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 24086000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 14932000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 134104000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 7654000.00
AMRN income_statement (quarterly, 2025-06-30) — Gross Profit: 50362000.00
AMRN cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 125000.00
AMRN income_statement (quarterly, 2025-06-30) — Interest Income: 2620000.00
AMRN income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 2620000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Inventory: 171244000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 464924000.00
AMRN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 12410000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 7338000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 7338000.00
AMRN income_statement (quarterly, 2025-06-30) — Net Income: -14139000.00
AMRN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -14139000.00
AMRN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -14139000.00
AMRN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -14139000.00
AMRN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -14139000.00
AMRN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -14139000.00
AMRN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -14139000.00
AMRN income_statement (quarterly, 2025-06-30) — Net Interest Income: 2620000.00
AMRN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 12410000.00
AMRN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 2620000.00
AMRN cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -720000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Net PPE: 7654000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 449992000.00
AMRN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 30262000.00
AMRN income_statement (quarterly, 2025-06-30) — Normalized Income: 3840610.00
AMRN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 16606000.00
AMRN income_statement (quarterly, 2025-06-30) — Operating Income: 6774000.00
AMRN income_statement (quarterly, 2025-06-30) — Operating Revenue: 72741000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 415401497.00
AMRN balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 17441000.00
AMRN income_statement (quarterly, 2025-06-30) — Other Gand A: 21215000.00
AMRN income_statement (quarterly, 2025-06-30) — Other Income Expense: -22844000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 14932000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 40721000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 11918000.00
AMRN income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -85000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Other Properties: 14000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 150827000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Payables: 44711000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 185946000.00
AMRN income_statement (quarterly, 2025-06-30) — Pretax Income: -13450000.00
AMRN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 57000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
AMRN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -37890000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Receivables: 119130000.00
AMRN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 22379000.00
AMRN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 729000.00
AMRN income_statement (quarterly, 2025-06-30) — Research And Development: 4915000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 300000.00
AMRN income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 22759000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1698382000.00
AMRN income_statement (quarterly, 2025-06-30) — Salaries And Wages: 2871000.00
AMRN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 50300000.00
AMRN income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 14587000.00
AMRN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 38673000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Share Issued: 428714819.00
AMRN income_statement (quarterly, 2025-06-30) — Special Income Charges: -22759000.00
AMRN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 6039000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 464924000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 449992000.00
AMRN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -4779390.00
AMRN income_statement (quarterly, 2025-06-30) — Tax Provision: 689000.00
AMRN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
AMRN balance_sheet (quarterly, 2025-06-30) — Total Assets: 670126000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 464924000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Total Debt: 7338000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 464924000.00
AMRN income_statement (quarterly, 2025-06-30) — Total Expenses: 65967000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 205202000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 63307000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 19256000.00
AMRN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -15985000.00
AMRN income_statement (quarterly, 2025-06-30) — Total Unusual Items: -22759000.00
AMRN income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -22759000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 13313322.00
AMRN balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 67108000.00
AMRN balance_sheet (quarterly, 2025-06-30) — Working Capital: 420873000.00
AMRN income_statement (quarterly, 2025-09-30) — +Operating Expense: 23905000.00
AMRN income_statement (quarterly, 2025-09-30) — +Total Revenue: 49670000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 36712000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 127309000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1922351000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -13987000.00
AMRN cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 866000.00
AMRN cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 866000.00
AMRN cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -830000.00
AMRN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 20776550.00
AMRN income_statement (quarterly, 2025-09-30) — Basic EPS: -0.40
AMRN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 148177000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 6731000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 310019000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 122802000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 286587000.00
AMRN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -248000.00
AMRN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -12129000.00
AMRN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -12697000.00
AMRN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -3713000.00
AMRN cash_flow (quarterly, 2025-09-30) — Change In Inventory: 17021000.00
AMRN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 26000.00
AMRN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -115000.00
AMRN cash_flow (quarterly, 2025-09-30) — Change In Payable: -3713000.00
AMRN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -3713000.00
AMRN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -12021000.00
AMRN cash_flow (quarterly, 2025-09-30) — Change In Receivables: -8150000.00
AMRN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -6952000.00
AMRN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -8179000.00
AMRN cash_flow (quarterly, 2025-09-30) — Changes In Cash: -25074000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Common Stock: 310019000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 458894000.00
AMRN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 27462000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 145521000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Current Assets: 628334000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 182233000.00
AMRN cash_flow (quarterly, 2025-09-30) — Depreciation: 1000.00
AMRN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 867000.00
AMRN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 867000.00
AMRN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 20776550.00
AMRN income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.40
AMRN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -7738000.00
AMRN income_statement (quarterly, 2025-09-30) — EBIT: -1697000.00
AMRN income_statement (quarterly, 2025-09-30) — EBITDA: -830000.00
AMRN cash_flow (quarterly, 2025-09-30) — End Cash Position: 123103000.00
AMRN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -248000.00
AMRN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -12697000.00
AMRN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 14343000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 14066000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 141296000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 7199000.00
AMRN income_statement (quarterly, 2025-09-30) — Gross Profit: 22208000.00
AMRN cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1000.00
AMRN income_statement (quarterly, 2025-09-30) — Interest Income: 2783000.00
AMRN income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2783000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Inventory: 184703000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 458894000.00
AMRN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -12129000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 6731000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 6731000.00
AMRN income_statement (quarterly, 2025-09-30) — Net Income: -7738000.00
AMRN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -7738000.00
AMRN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -7738000.00
AMRN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -7738000.00
AMRN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -7738000.00
AMRN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -7738000.00